Logo image of ACLS

AXCELIS TECHNOLOGIES INC (ACLS) Stock Fundamental Analysis

USA - NASDAQ:ACLS - US0545402085 - Common Stock

96.66 USD
+5.56 (+6.1%)
Last: 9/18/2025, 4:01:02 PM
96.66 USD
0 (0%)
After Hours: 9/18/2025, 4:01:02 PM
Fundamental Rating

7

Taking everything into account, ACLS scores 7 out of 10 in our fundamental rating. ACLS was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. ACLS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ACLS has a correct valuation and a medium growth rate. This makes ACLS very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ACLS was profitable.
In the past year ACLS had a positive cash flow from operations.
ACLS had positive earnings in each of the past 5 years.
Each year in the past 5 years ACLS had a positive operating cash flow.
ACLS Yearly Net Income VS EBIT VS OCF VS FCFACLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

1.2 Ratios

The Return On Assets of ACLS (11.97%) is better than 83.04% of its industry peers.
The Return On Equity of ACLS (15.50%) is better than 81.25% of its industry peers.
ACLS has a Return On Invested Capital of 12.23%. This is amongst the best in the industry. ACLS outperforms 83.93% of its industry peers.
ACLS had an Average Return On Invested Capital over the past 3 years of 21.34%. This is significantly above the industry average of 10.87%.
The 3 year average ROIC (21.34%) for ACLS is well above the current ROIC(12.23%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 11.97%
ROE 15.5%
ROIC 12.23%
ROA(3y)17.39%
ROA(5y)14.66%
ROE(3y)25.25%
ROE(5y)20.89%
ROIC(3y)21.34%
ROIC(5y)18.4%
ACLS Yearly ROA, ROE, ROICACLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

With a decent Profit Margin value of 17.69%, ACLS is doing good in the industry, outperforming 79.46% of the companies in the same industry.
In the last couple of years the Profit Margin of ACLS has grown nicely.
ACLS has a better Operating Margin (17.81%) than 75.89% of its industry peers.
ACLS's Operating Margin has improved in the last couple of years.
The Gross Margin of ACLS (44.90%) is comparable to the rest of the industry.
ACLS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.81%
PM (TTM) 17.69%
GM 44.9%
OM growth 3Y2.52%
OM growth 5Y24.03%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
ACLS Yearly Profit, Operating, Gross MarginsACLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ACLS is creating value.
The number of shares outstanding for ACLS has been reduced compared to 1 year ago.
The number of shares outstanding for ACLS has been reduced compared to 5 years ago.
The debt/assets ratio for ACLS has been reduced compared to a year ago.
ACLS Yearly Shares OutstandingACLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ACLS Yearly Total Debt VS Total AssetsACLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ACLS has an Altman-Z score of 8.10. This indicates that ACLS is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 8.10, ACLS is doing good in the industry, outperforming 68.75% of the companies in the same industry.
ACLS has a debt to FCF ratio of 0.35. This is a very positive value and a sign of high solvency as it would only need 0.35 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.35, ACLS belongs to the top of the industry, outperforming 81.25% of the companies in the same industry.
ACLS has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
ACLS's Debt to Equity ratio of 0.04 is fine compared to the rest of the industry. ACLS outperforms 60.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Altman-Z 8.1
ROIC/WACC1.07
WACC11.4%
ACLS Yearly LT Debt VS Equity VS FCFACLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

ACLS has a Current Ratio of 6.01. This indicates that ACLS is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.01, ACLS belongs to the best of the industry, outperforming 83.93% of the companies in the same industry.
A Quick Ratio of 4.26 indicates that ACLS has no problem at all paying its short term obligations.
ACLS's Quick ratio of 4.26 is fine compared to the rest of the industry. ACLS outperforms 74.11% of its industry peers.
Industry RankSector Rank
Current Ratio 6.01
Quick Ratio 4.26
ACLS Yearly Current Assets VS Current LiabilitesACLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The earnings per share for ACLS have decreased strongly by -28.37% in the last year.
The Earnings Per Share has been growing by 64.54% on average over the past years. This is a very strong growth
Looking at the last year, ACLS shows a very negative growth in Revenue. The Revenue has decreased by -19.38% in the last year.
The Revenue has been growing by 24.30% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-28.37%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-27.1%
Revenue 1Y (TTM)-19.38%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-24.16%

3.2 Future

The Earnings Per Share is expected to grow by 24.02% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -4.79% on average over the next years.
EPS Next Y-31.52%
EPS Next 2Y-17.23%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue Next Year-22.15%
Revenue Next 2Y-9.31%
Revenue Next 3Y-4.79%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ACLS Yearly Revenue VS EstimatesACLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
ACLS Yearly EPS VS EstimatesACLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.59, the valuation of ACLS can be described as rather expensive.
Based on the Price/Earnings ratio, ACLS is valued cheaper than 87.50% of the companies in the same industry.
ACLS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.20.
ACLS is valuated rather expensively with a Price/Forward Earnings ratio of 22.94.
Based on the Price/Forward Earnings ratio, ACLS is valued a bit cheaper than 73.21% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of ACLS to the average of the S&P500 Index (22.70), we can say ACLS is valued inline with the index average.
Industry RankSector Rank
PE 18.59
Fwd PE 22.94
ACLS Price Earnings VS Forward Price EarningsACLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

91.07% of the companies in the same industry are more expensive than ACLS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ACLS is valued cheaper than 84.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 24.72
EV/EBITDA 11.21
ACLS Per share dataACLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The excellent profitability rating of ACLS may justify a higher PE ratio.
A more expensive valuation may be justified as ACLS's earnings are expected to grow with 24.02% in the coming years.
PEG (NY)N/A
PEG (5Y)0.29
EPS Next 2Y-17.23%
EPS Next 3Y24.02%

0

5. Dividend

5.1 Amount

ACLS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AXCELIS TECHNOLOGIES INC

NASDAQ:ACLS (9/18/2025, 4:01:02 PM)

After market: 96.66 0 (0%)

96.66

+5.56 (+6.1%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-04 2025-11-04/amc
Inst Owners104.93%
Inst Owner Change-0.82%
Ins Owners0.94%
Ins Owner Change9.53%
Market Cap3.04B
Analysts72.86
Price Target99.26 (2.69%)
Short Float %14.79%
Short Ratio9.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)107.85%
Min EPS beat(2)51.76%
Max EPS beat(2)163.95%
EPS beat(4)4
Avg EPS beat(4)59.67%
Min EPS beat(4)2.16%
Max EPS beat(4)163.95%
EPS beat(8)8
Avg EPS beat(8)36.38%
EPS beat(12)12
Avg EPS beat(12)29.49%
EPS beat(16)16
Avg EPS beat(16)28.03%
Revenue beat(2)2
Avg Revenue beat(2)2.57%
Min Revenue beat(2)2.12%
Max Revenue beat(2)3.02%
Revenue beat(4)3
Avg Revenue beat(4)1.2%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)3.02%
Revenue beat(8)7
Avg Revenue beat(8)1.46%
Revenue beat(12)11
Avg Revenue beat(12)2.07%
Revenue beat(16)15
Avg Revenue beat(16)2.39%
PT rev (1m)11.71%
PT rev (3m)18.51%
EPS NQ rev (1m)-0.04%
EPS NQ rev (3m)35.67%
EPS NY rev (1m)25.39%
EPS NY rev (3m)24.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)7.09%
Revenue NY rev (1m)4.31%
Revenue NY rev (3m)4.4%
Valuation
Industry RankSector Rank
PE 18.59
Fwd PE 22.94
P/S 3.39
P/FCF 24.72
P/OCF 21.95
P/B 2.97
P/tB 2.97
EV/EBITDA 11.21
EPS(TTM)5.2
EY5.38%
EPS(NY)4.21
Fwd EY4.36%
FCF(TTM)3.91
FCFY4.04%
OCF(TTM)4.4
OCFY4.56%
SpS28.52
BVpS32.54
TBVpS32.54
PEG (NY)N/A
PEG (5Y)0.29
Profitability
Industry RankSector Rank
ROA 11.97%
ROE 15.5%
ROCE 13.92%
ROIC 12.23%
ROICexc 23.5%
ROICexgc 23.5%
OM 17.81%
PM (TTM) 17.69%
GM 44.9%
FCFM 13.71%
ROA(3y)17.39%
ROA(5y)14.66%
ROE(3y)25.25%
ROE(5y)20.89%
ROIC(3y)21.34%
ROIC(5y)18.4%
ROICexc(3y)45.35%
ROICexc(5y)37.49%
ROICexgc(3y)45.35%
ROICexgc(5y)37.49%
ROCE(3y)24.29%
ROCE(5y)20.95%
ROICexcg growth 3Y-3.61%
ROICexcg growth 5Y39%
ROICexc growth 3Y-3.61%
ROICexc growth 5Y39%
OM growth 3Y2.52%
OM growth 5Y24.03%
PM growth 3Y9.84%
PM growth 5Y31.85%
GM growth 3Y1.09%
GM growth 5Y1.22%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.35
Debt/EBITDA 0.24
Cap/Depr 91.25%
Cap/Sales 1.73%
Interest Coverage 250
Cash Conversion 78.35%
Profit Quality 77.5%
Current Ratio 6.01
Quick Ratio 4.26
Altman-Z 8.1
F-Score6
WACC11.4%
ROIC/WACC1.07
Cap/Depr(3y)109.12%
Cap/Depr(5y)96.53%
Cap/Sales(3y)1.4%
Cap/Sales(5y)1.41%
Profit Quality(3y)77.07%
Profit Quality(5y)99.84%
High Growth Momentum
Growth
EPS 1Y (TTM)-28.37%
EPS 3Y28.48%
EPS 5Y64.54%
EPS Q2Q%-27.1%
EPS Next Y-31.52%
EPS Next 2Y-17.23%
EPS Next 3Y24.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.38%
Revenue growth 3Y15.4%
Revenue growth 5Y24.3%
Sales Q2Q%-24.16%
Revenue Next Year-22.15%
Revenue Next 2Y-9.31%
Revenue Next 3Y-4.79%
Revenue Next 5YN/A
EBIT growth 1Y-38.8%
EBIT growth 3Y18.31%
EBIT growth 5Y54.17%
EBIT Next Year-45.91%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-49.07%
FCF growth 3Y-3.13%
FCF growth 5YN/A
OCF growth 1Y-45.47%
OCF growth 3Y-2.13%
OCF growth 5YN/A